Direct STAT5 phosphorylation by mammalian target of rapamycin (mTOR) could modulate the expression and nuclear localisation of sterol regulatory element binding protein-1 (SREBP1) to promote lipid synthesis in the liver, which could result in the onset of HCC [95]. Here, MTOR is linked to hepatocellular carcinoma.